All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
AMRS / Amyris Inc
|
|
|
|
|
|
|
|
OCGN / Ocugen, Inc.
|
|
|
|
|
|
|
|
VBLT / Vascular Biogenics Ltd
|
|
|
|
|
|
|
|
FAMI / Farmmi, Inc.
|
|
|
|
|
|
|
|
SAVA / Cassava Sciences, Inc.
|
|
|
|
|
|
|
|
KTRA / Kintara Therapeutics, Inc.
|
|
|
|
|
|
|
|
PSTV / Plus Therapeutics, Inc.
|
|
|
|
|
|
|
|
ABEO / Abeona Therapeutics Inc.
|
|
|
|
|
|
|
|
BCEL / Atreca, Inc.
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SVRA / Savara Inc.
|
|
|
|
|
|
|
|
OPRA / Opera Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
VUZI / Vuzix Corporation
|
|
|
|
|
|
|
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
|
|
|
|
|
HEXO / HEXO Corp
|
|
|
|
|
|
|
|
LPCN / Lipocine Inc.
|
|
|
|
|
|
|
|
BVXVW / BiondVax Pharmaceuticals Ltd., Warrant
|
|
|
|
|
|
|
|
XCUR / Exicure, Inc.
|
|
|
|
|
|
|
|
MCF / Contango Oil & Gas Company
|
|
|
|
|
|
|
|
NBRV / Nabriva Therapeutics Plc
|
|
|
|
|
|
|
|
REPL / Replimune Group, Inc.
|
|
|
|
|
|
|
|
US887399AA15 / TimkenSteel Corporation Bond
|
|
|
|
|
|
|
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BTAI / BioXcel Therapeutics, Inc.
|
|
|
|
|
|
|
|
TEUM / Pareteum Corp
|
|
|
|
|
|
|
|
TPTX / Turning Point Therapeutics Inc
|
|
|
|
|
|
|
|
APDNW / Applied DNA Sciences, Inc., Warrants
|
|
|
|
|
|
|
|
SESN / Sesen Bio Inc.
|
|
|
|
|
|
|
|
AIHS / Senmiao Technology Limited
|
|
|
|
|
|
|
|
/ InspireMD Inc. Series B Warrants, exercisable for one share of common stock (Expiring March 14, 2022
|
|
|
|
|
|
|
|
68232V116 / Onconova Therapeutics, Inc. Warrants
|
|
|
|
|
|
|
|
ARTL / Artelo Biosciences, Inc.
|
|
|
|
|
|
|
|
BNTCW / Benitec Biopharma Ltd
|
|
|
|
|
|
|
|
MNKD / MannKind Corporation
|
|
|
|
|
|
|
|
FPAY / FlexShopper, Inc.
|
|
|
|
|
|
|
|
SEEL / Seelos Therapeutics, Inc.
|
|
|
|
|
|
|
|
SNGX / Soligenix, Inc.
|
|
|
|
|
|
|
|
AUMN / Golden Minerals Company
|
|
|
|
|
|
|
|
SHIP / Seanergy Maritime Holdings Corp.
|
|
|
|
|
|
|
|
SGLB / Sigma Labs Inc
|
|
|
|
|
|
|
|
ENVB / Enveric Biosciences, Inc.
|
|
|
|
|
|
|
|
PHIO / Phio Pharmaceuticals Corp.
|
|
|
|
|
|
|
|
TCOM / Trip.com Group Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ADMP / Adamis Pharmaceuticals Corp
|
|
|
|
|
|
|
|
NAK / Northern Dynasty Minerals Ltd.
|
|
|
|
|
|
|
|
UUUU.WS / Energy Fuels Inc.
|
|
|
|
|
|
|
|
SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
81727UAA3 / Senseonics Hldgs Inc Bond
|
|
|
|
|
|
|
|
CREX / Creative Realities, Inc.
|
|
|
|
|
|
|
|
QNRX / Quoin Pharmaceuticals, Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ESGC / Eros STX Global Corporation - Class A
|
|
|
|
|
|
|
|
MDGS / Medigus Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CRMD / CorMedix Inc.
|
|
|
|
|
|
|
|
AMPE / Ampio Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CHEK / Check-Cap Ltd.
|
|
|
|
|
|
|
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
|
|
|
|
|
AEHL / Antelope Enterprise Holdings Limited
|
|
|
|
|
|
|
|
RGLS / Regulus Therapeutics Inc.
|
|
|
|
|
|
|
|
VERBW / Verb Technology Company Inc - Warrants (14/03/2024)
|
|
|
|
|
|
|
|